Patents by Inventor Thomas Engelbrecht Norkild Jonassen

Thomas Engelbrecht Norkild Jonassen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phenyl pyrrole aminoguanidine derivatives
    Patent number: 8058306
    Abstract: The present invention relates to phenyl pyrrole aminoguanidine derivatives of the general formula (I): (I) including tautomeric forms thereof, wherein n is 1, 2 or 3; or a pharmaceutically acceptable salt thereof. The present invention further relates to the use of such phenyl pyrrole aminoguanidine derivatives for the treatment of diseases associated with the melanocortin receptors or related systems, e.g. the melanocyte stimulating hormones.
    Type: Grant
    Filed: June 11, 2007
    Date of Patent: November 15, 2011
    Assignee: Action Pharma A/S
    Inventors: Arne Boman, Thomas Engelbrecht Norkild Jonassen, Torbjorn Lundstedt
  • PHENYL PYRROLE AMINOGUANIDINE DERIVATIVES
    Publication number: 20110082183
    Abstract: The present invention relates to phenyl pyrrole aminoguanidine derivatives of the general formula (I): (I) including tautomeric forms thereof, wherein n is 1, 2 or 3; or a pharmaceutically acceptable salt thereof. The present invention further relates to the use of such phenyl pyrrole aminoguanidine derivatives for the treatment of diseases associated with the melanocortin receptors or related systems, e.g. the melanocyte stimulating hormones.
    Type: Application
    Filed: June 11, 2007
    Publication date: April 7, 2011
    Applicant: Action Pharma A/S
    Inventors: Arne Boman, Thomas Engelbrecht Norkild Jonassen, Torbjorn Lundstedt
  • Methods for treatment of diseases associated with inflammation under non-ischemic conditions
    Publication number: 20020061849
    Abstract: A disease associated with inflammation under non-ischemic conditions is treated or prevented by administering (1) &agr;-melanocyte simulating hormone (&agr;-MSH) and/or a &agr;-MSH equivalent, and/or (2) erythropoietin (EPO) and/or an EPO equivalent, to the individual in need thereof.
    Type: Application
    Filed: May 2, 2001
    Publication date: May 23, 2002
    Inventors: Soren Nielsen, Jorgen Frokiaer, Thomas Engelbrecht Norkild Jonassen, Thorbjorn Bjerke
  • Use of alpha-MSH and EPO for preventing or treating ischemic conditions
    Publication number: 20020037832
    Abstract: Alpha—melanocyte stimulating hormone (&agr;-MSH) or an equivalent is used, in conjunction with erythropoietin (EPO) or equivalent, to prevent or treat ischemic conditions.
    Type: Application
    Filed: May 2, 2001
    Publication date: March 28, 2002
    Inventors: Soren Nielsen, Jorgen Frokiaer, Thomas Engelbrecht Norkild Jonassen, Thorbjorn Bjerke